The latest price and usage costs of pemigatinib

Pemigatinib (Pemigatinib) is a targeted therapy drug mainly used to treat cholangiocarcinoma (CCA) caused by FGFR2 gene mutations. The drug has been launched in the domestic market, but has not yet been included in the scope of medical insurance reimbursement, so patients need to bear higher drug costs when using it. According to the current market conditions, the price of pemetinib fluctuates to a certain extent, which is mainly affected by factors such as drug specifications, purchase channels, and exchange rate changes.

In the Chinese market, the common specifications of pemetinib are4.5mg 14 tablets and 9mg 14 tablets. Depending on the manufacturer and sales channel, the price range is roughly RMB 20,000 to RMB 50,000 per box. This price is relatively high, which may cause a considerable financial burden, especially for patients without medical insurance coverage. It should be noted that since drugs are imported drugs, their prices are greatly affected by import costs and distribution fees. Therefore, prices will also vary between different regions and pharmacies.

In overseas markets, the price of pemetinib is usually higher. For example, taking the specification of 13.5mg*14 tablets, the price per box may reach more than RMB 70,000. Due to market price differences and exchange rate fluctuations in different countries, patients need to consider comprehensively when choosing purchasing channels. For those patients with limited financial conditions, they may choose to travel to lower-priced areas or obtain the drug through international drug procurement channels.

In addition to the original drug, generic versions of pemetinib are also on the market in some countries. Generic drugs are usually more affordable and have similar efficacy to the original drugs. Take the generic version of pemetinib produced by Lucius Pharmaceuticals in Laos as an example. The specification is 4.5mg*14 tablets, and each box is priced at just over RMB 700 (the specific price will vary due to exchange rate fluctuations). Although generic drugs are cheap, patients still need to pay attention to the quality and source of the drugs when choosing, and ensure that they purchase drugs from formal channels.

Reference materials:https://go.drugbank.com/drugs/DB15102